Lek once again receives AmCham Slovenia Award for Best Business Practice
- Our Young Advisory Board (YAB)initiative has been awarded the coveted title of Best Business Practice, presented by AmCham Slovenia through their Best of the Best program.
- The Young Advisory Board, which this year is in its fourth generation, enables young associates to contribute to the development of Lek's professional and business environment.
- Last year, Lek received the award for the project Industry and University –Building a Society of Knowledge and Prosperity Together, which the company is implementing together with theLjubljana University Incubator and the University of Ljubljana.
Lek, a Sandoz company and a leading producer of generics and biosimilars, has once again received the Best of the Best award for business practice, presented by AmCham Slovenia. The members of the jury and the votes cast selected Lek’s Youth Advisory Board initiative as the best among the three finalists.
AmCham Slovenia’s Best of the Best program has been organizing for the tenth year and was conceived as a guide, inspiration and aid in transferring new knowledge and positive business experiences. This year, Lek participated in the competition with the Youth Advisory Board or YAB initiative, whose goal is to contribute to the professional and business development of the company. This creates an interdisciplinary community that promotes new ways of thinking. YAB is in its fourth year of operation and we are proud to receive more and more applications every year.
"We are extremely proud to have been selected as a winner of the Best Business Practice Award for the second time in a row. With the Youth Advisory Board, we have managed to build a truly close-knit community of young talented individuals who meet regularly with the company's top management, share best practices and contribute with their original ideas to help our company set trends and open up new development opportunities through innovation. All members proactively contribute to the strategic ways of thinking and propose innovative solutions for reaching business goals and the company’s overall development," stated YAB Lead, Irenej Jerič.
In addition to Lek, the Best of the Best super finalists also included the company Mega M for its smart solutions to effective energy management, as well as the Triglav insurance company together with AMZS for their joint project offering refresher driving courses for the elderly.
About Lek
Lek, a Sandoz company, is the first and oldest pharmaceutical company in Slovenia, developing, manufacturing and marketing effective, safe and high-quality generics and biosimilars for patients around the world. Our work is guided by strong ethical standards, innovative thinking and the breakthrough achievements of our world-class professionals. With more than 3,700 associates, we have been actively shaping the Slovenian, European and global research and development landscape for decades. We are building a culture of open dialog, and we proudly and responsibly hold the title of most reputable employer in Slovenia.
About Sandoz
Sandoz (SIX: SDZ; OTCQX: SDZNY) is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients. 22,000 people of more than 100 nationalities work together to bring Sandoz medicines to some 500million patients worldwide, generating substantial global healthcare savings and making an even larger total social impact. Its leading portfolio of more than 1,500 products addresses diseases from the common cold to cancer.Headquartered in Basel, Switzerland, Sandoz traces its heritage back to the year 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the world’s first biosimilar in2006. In 2022, Sandoz achieved sales of USD 9.1 billion and core EBITDA of USD1.9 billion.
Disclaimer
This Media Release contains forward-looking statements which offer no guarantee with regard to future performance. These statements are made on the basis of management’s views and assumptions regarding future events and business performance at the time the statements are made. They are subject to risks and uncertainties including, but not confined to, future global economic conditions, exchange rates, legal provisions, market conditions, activities by competitors and other factors outside of the control of Sandoz. Should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect, actual outcomes may vary materially from those forecasted or expected. Each forward-looking statement speaks only as of the date of the particular statement, and Sandoz undertakes no obligation to publicly update or revise any forward-looking statements, except as required by law.
